Skip to main content
NCBI home page
Cellular and Molecular Neurobiology logoLink to Cellular and Molecular Neurobiology
. 2005 Feb;25(1):5–23. doi: 10.1007/s10571-004-1374-y

Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation

N Joan Abbott 1,2,✉
PMCID: PMC11529509  PMID: 15962506

Abstract

1. Three main barrier layers at the interface between blood and tissue protect the central nervous system (CNS): the endothelium of brain capillaries, and the epithelia of the choroid plexus (CP) and the arachnoid. The classical work on these barriers in situ until the 1970s laid the foundations for modern understanding. Techniques for brain endothelial cell isolation and culture pioneered by Ferenc Joó in the 1970s opened up new fields of examination, enabling study of mechanisms at the cellular and molecular level.

2. Astrocytic glial cells are closely associated with the brain endothelial barrier. During evolution the barrier appears to have shifted from the glial to the endothelial layer, in parallel with the increasing importance of the microvasculature and its regulation. Vestiges of the barrier potential of glia remain in the modern mammalian CNS.

3. Evolutionary evidence suggests that the advantage derived from ionic homeostasis around central synapses was the major selective pressure leading to refinement of CNS barrier systems. This is one element of the modern multitasking’ barrier function.

4. While epithelia are constitutively able to form barriers at appropriate interfaces, the ‘default’ condition for endothelia is more leaky; inductive influences from associated cells especially astrocytes are important in generating the full blood–brain barrier (BBB) phenotype in brain capillaries. The underlying mechanisms are being elucidated at the molecular and genomics level.

5. The barrier layers of the nervous system can be modulated by a number of receptor-mediated processes, involving several signal transduction pathways, both calcium dependent and independent. Some agents acting as ‘inducers’ in the long term can act as ‘modulators’ in the short-term, with some overlap of signaling pathways. Modulating agents may be derived both from the blood and from cells associated with cerebral vessels. Less is known about the modulation of the CP.

6. The challenge for the next era of CNS barrier studies will be to apply new knowledge from proteomics and genomics to understanding the in vivo condition in physiology and pathology.

Key words: blood–brain barrier, CNS, evolution, induction, modulation

References

  1. Abbott, N. J. (1992). Comparative physiology of the blood–brain barrier. In Bradbury, M. W. B. (ed.), Physiology and Pharmacology of the Blood–Brain Barrier, Springer-Verlag, Heidelberg, pp. 371–396. [Google Scholar]
  2. Abbott, N. J. (1998). Role of intracellular calcium in regulation of brain endothelial permeability. In Pardridge W. M. (ed.) Introduction to the Blood–Brain Barrier: Methodology and Biology, Cambridge University Press, Cambridge, UK, pp. 345–353. [Google Scholar]
  3. Abbott, N. J. (2000). Inflammatory mediators and modulation of blood–brain barrier permeability. Cell. Molec. Neurobiol.20:31–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Abbott, N. J. (2002). Astrocyte–endothelial interactions and blood–brain barrier permeability. J. Anat.200:629–638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Abbott, N. J., and Revest, P. A. (1991). Control of brain endothelial permeability. Cerebrovasc. Brain Metab. Rev.3:39–72. [PubMed] [Google Scholar]
  6. Abbott, N. J., and Romero, I. A. (1996). Transporting therapeutics across the blood–brain barrier. Molec. Med. Today2:106–113. [DOI] [PubMed] [Google Scholar]
  7. Abbott, N. J., and Romero, I. A. (1999). Patterns of toxic damage to brain endothelium in relation to cell metabolism. In Paulson, O., Moos Knudsen, G., and Moos, T. (eds.), Brain Barrier Systems, Alfred Benzon Symposium No 45, Munksgaard, Copenhagen, pp. 269–279. [Google Scholar]
  8. Abbott, N. J., Bundgaard, M., and Cserr, H. F. (1986a). Comparative physiology of the blood–brain barrier. In Suckling, A. J., Rumsby, M. G., and Bradbury, M. W. (eds.) The Blood–Brain Barrier in Health and Disease, Ellis Horwood, Chichester, UK, pp. 52–72. [Google Scholar]
  9. Abbott, N. J., Lane, N. J., and Bundgaard, M. (1986b). The blood–brain interface in invertebrates. Ann. NY Acad. Sci. 481:20–41. [DOI] [PubMed] [Google Scholar]
  10. Abbott, N. J., Mendonca, L. L. F., and Dolman, D. E. M. (2003). The blood–brain barrier in systemic lupus erythematosus. Lupus. 12:908–915. [DOI] [PubMed] [Google Scholar]
  11. Abbott, N. J., Revest, P. A., and Romero, I. A. (1992). Astrocyte–endothelial interaction: Physiology and pathology. Neuropath. Appl. Neurobiol.18:424–433. [DOI] [PubMed] [Google Scholar]
  12. Abbott, N. J., Mitchell, G., Ward, K. J., Abdullah, F., and Smith, I. C. H. (1997). An electrophysiological method for measuring the potassium permeability of the nerve perineurium. Brain Res.776:204–213. [DOI] [PubMed] [Google Scholar]
  13. Abbott, N. J., Zlokovic, B. V., Taylor, M., Hart, J., and Rogac, L. (1988). Amino acid transport by a glial blood–brain barrier: Studies in an elasmobranch fish. In Rakic, L., Begley, D. J., Davson, H., and Zlokovic B. V. (eds.), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System, Macmillan Press and Serbian Academy of Sciences and Arts, London and Belgrade, pp. 241–244. [Google Scholar]
  14. Ábrahám, C. S., Deli, M. A., Joó, F., Megyeri, P., and Torpier, G. (1996). Intracarotid tumour necrosis factor-α administration increases the blood–brain barrier permeability in the cerebral cortex of newborn pig: Quantitative aspects of double labelling studies and confocal laser scanning analysis. Neurosci. Lett. 208:85–88. [DOI] [PubMed] [Google Scholar]
  15. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2002). Molecular Biology of the Cell, 4th edn., Garland Science, New York. [Google Scholar]
  16. Allt, G., and Lawrenson, J. G. (1997). Is the pial microvessel a good model for blood–brain barrier studies? Brain Res. Rev.24:67–76. [DOI] [PubMed] [Google Scholar]
  17. Allt, G., and Lawrenson, J. G. (2000). The blood–nerve barrier: Enzymes, transporters and receptors—a comparison with the blood–brain barrier. Brain Res. Bull.52:1–12. [DOI] [PubMed] [Google Scholar]
  18. Allt, G., and Lawrenson, J. G. (2001). Pericytes: Cell biology and pathology. Cells Tissue Organs169:1–11. [DOI] [PubMed] [Google Scholar]
  19. Amédée, T., Robert, A., and Coles, J. A. (1997). Potassium homeostasis and glial energy metabolism. Glia21:46–55. [DOI] [PubMed] [Google Scholar]
  20. Arlotta, P., Magavi, S. S., and Macklis, J. D. (2003). Molecular manipulation of neural precursors in situ: Induction of adult cortical neurogenesis. Exp. Gerontol.38:173–182. [DOI] [PubMed] [Google Scholar]
  21. Arsenijevic, D., Girardier, L., Seydoux, J., Pechere, J. C., Garcia, I., Lucas, R., Change, H. R., and Dulloo, A. G. (1998). Metabolic–cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection. Am. J. Physiol.274: E439–E445. [DOI] [PubMed] [Google Scholar]
  22. Balda, M. S., Flores-Maldonado, C., Cereijido, M., and Matter, K. (2000). Multiple domains of occludin are involved in the regulation of paracellular permeability. J. Cell Biochem.78:85–96. [PubMed] [Google Scholar]
  23. Balda, M. S., Whitney, J. A., Flores, C., Gonzáles, S., Cereijido, M., and Matter, K. (1996). Functional dissociation of paracellular permeability and transepithelial resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell. Biol.134:1031–1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Bauer, H. C., and Bauer, H. (2000). Neural induction of the blood–brain barrier: Still an enigma. Cell. Molec. Neurobiol.20:13–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Bradbury, M. W. B. (1979). The Concept of a Blood–Brain Barrier, Wiley, Chichester, UK. [Google Scholar]
  26. Brightman, M. W. (1992) Ultrastructure of brain endothelium. In Bradbury, M. W. B. (ed.), Physiology and Pharmacology of the Blood–Brain Barrier, Springer-Verlag, Heidelberg, pp. 1–22. [Google Scholar]
  27. Brightman, M. W., and Reese, T. S. (1969). Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol.40:648–677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Butt, A. M. (1995). Effect of inflammatory agents on electrical resistance across the blood–brain barrier in pial microvessels of anaesthetized rats. Brain Res.696:145–50. [DOI] [PubMed] [Google Scholar]
  29. Butt, A. M., Jones, H. C., and Abbott, N. J. (1990). Electrical resistance across the blood–brain barrier in anaesthetized rats: A developmental study. J. Physiol.429:47–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Chen, K. C., and Nicholson, C. (2000). Spatial buffering of potassium ions in brain extracellular space. Biophys. J.78:2776–2797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Conti, L., Cataudella, T., and Cattaneo, E. (2003). Neural stem cells: A pharmacological tool for brain diseases? Pharmacol. Res. 47:289–297. [DOI] [PubMed] [Google Scholar]
  32. Cserr, H. F., and Bundgaard, M. (1984). Blood–brain interface in vertebrates: A comparative approach. Am. J. Physiol.R246:277–288. [DOI] [PubMed] [Google Scholar]
  33. Cserr, H. F., and Patlak, C. S. (1992) Secretion and bulk flow of interstitial fluid. In Bradbury, M. W. B. (ed.), Physiology and Pharmacology of the Blood–Brain Barrier, Springer Verlag, Berlin, pp. 245–261. [Google Scholar]
  34. Davson, H., and Segal, M. B. (1995). Physiology of the CSF and the Blood–Brain Barrier, CRC Press, New York. [Google Scholar]
  35. De Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., and Breimer, D. D. (1997). The blood–brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49:143–155. [PubMed] [Google Scholar]
  36. Dehouck, M.-P., Meresse, S., Delorme, P., Fruchart, J.-C., and Cecchelli, R. (1990). An easier, reproducible, and mass-production method to study the blood–brain barrier in vitro. J. Neurochem.54:1798–1801. [DOI] [PubMed] [Google Scholar]
  37. Deli, M. A., Ábrahám, C. S., Kataoka, Y., and Niwa, M. (2005). Permeability studies on in vitro BBB models: Physiology, pathology, pharmacology. Cell. Molec. Neurobiol.25:59–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Demeule, M., Regina, A., Jodoin, J., Laplante, A., Dagenais, C., Berthelet, F., Moghrabi, A., and Beliveau, R. (2002). Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood–brain barrier. Vasc. Pharmacol. 38:339–348. [DOI] [PubMed] [Google Scholar]
  39. Desai, S., Marroni, M., Cucullo, L., Bengez, L., Mayberg, M., Hosssain, M., Grant, G., and Janigro, D. (2002). Mechanisms of endothelial survival under shear stress. Endothelium9:89–102. [DOI] [PubMed] [Google Scholar]
  40. Doolittle, N. D., Miner, M. E., Hall, W. A., Siegal, T., Jerome, E., Osztie, E., McAllister, L. D., Bubalo, J. S., Kraemer, D. F., Fortin, D., Nixon, R., Muldoon, L. L., and Neuwelt, E. A. (2000). Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood–brain barrier for the treatment of patients with malignant brain tumours. Cancer88:637–647. [DOI] [PubMed] [Google Scholar]
  41. Duport, S., Robert, F., Muller, D., Grau, G., Parisi, L., and Stoppini, L. (1998). An in vitro blood–brain barrier model: Cocultures between endothelial cells and organotypic brain slice cultures. Proc. Natl. Acad. Sci. USA95:1840–1845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Easton, A. S., and Abbott, N. J. (2002). Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood–brain barrier. Brain Res.953:157–169. [DOI] [PubMed] [Google Scholar]
  43. Easton, A. S., Sarker, M. H., and Fraser, P. A. (1997). Two components of blood–brain barrier disruption in the rat. J. Physiol.503:613–623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. El Hafny, B., Bourre, J.-M., and Roux, F. (1996). Synergistic stimulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol.167:451–460. [DOI] [PubMed] [Google Scholar]
  45. El Hafny, B., Chappey, O., Piciotti, M., Debray, M., Boval, B., and Roux, F. (1997). Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. Neurosci. Lett.236:107–111. [DOI] [PubMed] [Google Scholar]
  46. Engelhardt, B., and Risau, W. (1995). Development of the blood–brain barrier. In Greenwood, J., Begley, D. J., and Segal, M. B. (eds), New Concepts of the Blood–Brain Barrier, Plenum Press, New York and London, pp. 11–33. [Google Scholar]
  47. Fenstermacher, J., Nakata, H., Tajima, A., Yen, M.-H., Acuff, V., and Gruber, K. (1992). Structural, ultrastructural and functional correlations among local capillary systems within the brain. In: Segal, M. B. (ed.), Barriers and Fluids of the Eye and Brain, Macmillan Press, London, pp. 59–71. [Google Scholar]
  48. Gaillard, P. J., and de Boer, A. G. (2000). Relationship between permeability status of the blood–brain barrier and in vitro permeability coefficient of a drug. Eur. J. Pharm. Sci.12:95–102. [DOI] [PubMed] [Google Scholar]
  49. Ghersi-Egea, J. F., Finnegan, W., Chen, J. L., and Fenstermacher, J. D. (1996). Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience75:1271–1288. [DOI] [PubMed] [Google Scholar]
  50. Haseloff, R. F., Blasig I. E., Bauer, H.-C., and Bauer, H. (2005). In search of the astrocytic factor(s) modulating blood–brain barrier functions in brain capillary endothelial cells in vitro. Cell. Molec. Neurobiol.25:25–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Hickey, W. F. (2001). Basic principles of immunological surveillance of the normal central nervous system. Glia36:118–124. [DOI] [PubMed] [Google Scholar]
  52. Hoheisel, D., Nitz, T., Franke, H., Wagner, J., Hakvoort, A., Tilling, T., and Galla, H. J. (1998). Hydrocortisone reinforces the blood–brain barrier properties in a serum free cell culture system. Biochem. Biophys. Res. Comm.247:312–315. [DOI] [PubMed] [Google Scholar]
  53. Hosoya, K., Ohtsuki, S., and Terasaki, T. (2002). Recent advances in the brain-to-blood efflux transport across the blood–brain barrier. Int. J. Pharm.248:15–29. [DOI] [PubMed] [Google Scholar]
  54. Huber, J. D., Egleton, R. D., and Davis, T. P. (2001). Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier. Trends Neurosci.24:719–725. [DOI] [PubMed] [Google Scholar]
  55. Hurst, R. D., and Fritz, I. B. (1996a). Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood–brain barrier. J. Cell. Physiol.167:81–88. [DOI] [PubMed] [Google Scholar]
  56. Hurst, R. D., and Fritz, I. B. (1996b) Nitric oxide-induced perturbations in a cell culture model of the blood–brain barrier. J. Cell. Physiol.167:89–94. [DOI] [PubMed] [Google Scholar]
  57. Igarashi, Y., Utsumi, H., Chiba, H., Yamada-Sasamori, Y., Tobioka, H., Kamimura, Y., Furuuchi, K., Kokai,Y., Nakagawa, T., Mori, M., and Sawada N. (1999). Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood–brain barrier. Biochem. Biophys. Res. Commun.261:108–112. [DOI] [PubMed] [Google Scholar]
  58. Joó, F., and Karnushina, I. (1973). A procedure for the isolation of capillaries from rat brain. Cytobios8:41–48. [PubMed] [Google Scholar]
  59. Kacem, K., Lacombe, P., Seylaz, J., and Bonvento, G. (1998). Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study. Glia23:1–10. [PubMed] [Google Scholar]
  60. Konsman, J. P., Tridon, V., and Dantzer, R. (2000). Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience101:957–967. [DOI] [PubMed] [Google Scholar]
  61. Kraemer, D. F., Fortin, D., and Neuwelt, E. A. (2002). Chemotherapeutic dose intensification for treatment of malignant brain tumors: Recent developments and future directions. Curr. Neurol. Neurosci.Rep.2:216–224. [DOI] [PubMed] [Google Scholar]
  62. Krämer, S. D., Abbott, N. J., and Begley, D. J. (2001). Biological models to study blood–brain barrier permeation. In Testa, B., van de Waterbeemd, H., Folkers, G., and Guy, R. (eds.), Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical and Computational Strategies, Weinheim, Wiley-VCH, pp. 127–153. [Google Scholar]
  63. Krum, J. M., Kenyon, K. L., and Rosenstein, J. M. (1997). Expression of blood–brain barrier characteristics following neuronal loss and astroglial damage after administration of anti-Thy-1 immunotoxin. Exp. Neurol.146:33–45. [DOI] [PubMed] [Google Scholar]
  64. Li, J. Y., Boado, R. J., and Pardridge, W. M. (2001). Blood–brain barrier genomics. J. Cereb. Blood Flow Metab.21:61–68. [DOI] [PubMed] [Google Scholar]
  65. Mandel, L. J., Bacallao, R., and Zampighi, G. (1993). Uncoupling of the molecular “fence” and paracellular “gate” functions of epithelial tight junctions. Nature361:552–555. [DOI] [PubMed] [Google Scholar]
  66. Male, D. K. (1992). Immunology of brain endothelium and the blood–brain barrier. In Bradbury, M. W. B. (ed.), Physiology and Pharmacology of the Blood–Brain Barrier, Springer Verlag, Berlin, pp. 397–415. [Google Scholar]
  67. Marroni, M., Marchi N., Cucullo, L., Abbott, N. J., Signorelli, K., and Janigro, D. (2003). Vascular and parenchymal mechanisms in multiple drug resistance: A lesson from human epilepsy. Curr. Drug Targets4:279–304. [DOI] [PubMed] [Google Scholar]
  68. Mayhan, W. G. (2001). Regulation of blood–brain barrier permeability. Microcirculation8:89–104. [DOI] [PubMed] [Google Scholar]
  69. Mizuguchi, H., Utoguchi, N., and Mayumi, T. (1997). Preparation of glial extracellular matrix: A novel method to analyze glial–endothelial interaction. Brain Res. Protoc.1:339–343. [DOI] [PubMed] [Google Scholar]
  70. Moos, T. (2002). Brain iron homeostasis. Danish Med. Bull.49:279–301. [PubMed] [Google Scholar]
  71. Nagy, Z., Peters, H., and Hüttner, I. (1984). Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab. Invest.50:313–322. [PubMed] [Google Scholar]
  72. Nobles, M., Revest, P. A., Couraud, P.-O., and Abbott, N. J. (1995). Characteristics of nucleotide receptors that cause elevation of cytoplasmic calcium in immortalized rat brain endothelial cells (RBE4) and in primary cultures. Br. J. Pharmacol.115:1245–1252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Nobles, M., and Abbott, N. J. (1996). Adhesion and growth of brain microvascular endothelial cells on treated glass. Endothelium4:297–307. [Google Scholar]
  74. Nobles, M., and Abbott, N. J. (1998). Modulation of the effects of extracellular ATP on [Ca2+]i in rat brain microvascular endothelial cells. Eur. J. Pharmacol.361:19–127. [DOI] [PubMed] [Google Scholar]
  75. Olesen, S.-P. (1989). An electrophysiological study of microvascular permeability and its modulation by chemical mediators. Acta Physiol. Scand.136(Suppl. 579):1–28. [PubMed] [Google Scholar]
  76. Papadopoulos, M. C., Saadoun, S., Woodrow, C. J., Davis, D. C., Costa-Martins, P., Moss, R. F., Krishna, S., and Bell, B. A. (2001). Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropath. Appl. Neurobiol. 27:384–395. [DOI] [PubMed] [Google Scholar]
  77. Pasqualini, R., Arap, W., and McDonald, D. M. (2002). Probing the structural and molecular diversity of tumor vasculature. Trends Molec. Med.8:563–571. [DOI] [PubMed] [Google Scholar]
  78. Perry, V. H., Anthony, D. C., Bolton, S. J., and Brown H. C. (1997). The blood–brain barrier and the inflammatory response. Mol. Med. Today3:225–341. [DOI] [PubMed] [Google Scholar]
  79. Plumb, J., McQuaid. S., Mirakur, M., and Kirk, J. (2002). Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Path.12:154–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Proescholdt, M. G., Hutto, B., Brady, L. S., and Herkenham, M. (2000). Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat. Neuroscience2:577–592. [DOI] [PubMed] [Google Scholar]
  81. Ramsauer, M., Krause, D., and Dermietzel, R. (2002). Angiogenesis of the blood–brain barrier in vitro and the function of cerebral pericytes. FASEB J. 16:1274–1276. [DOI] [PubMed] [Google Scholar]
  82. Rapoport, S. I. (2001). Advances in osmotic opening of the blood–brain barrier to enhance CNS chemotherapy. Expert Opin. Investig. Drugs10:1809–1818. [DOI] [PubMed] [Google Scholar]
  83. Regina, A., Koman, A., Piciotti, M., El Hafny, B., Center, M. S., Bergmann, R., Couraud, P. O., and Roux, F. (1998). Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem.71:705–715. [DOI] [PubMed] [Google Scholar]
  84. Reichel, A., Begley, D. J., and Abbott, N. J. (2003). An overview of in vitro techniques for blood–brain barrier studies. In Nag, S. (ed.), The Blood–Brain Barrier, Biology and Research Protocols, Humana Press, Totowa, New Jersey, pp. 307–324. [DOI] [PubMed] [Google Scholar]
  85. Reinhart, C. A., and Gloor, S. M. (1997). Co-culture blood–brain barrier models and their use for pharmatoxicological screening. Toxicol. in Vitro11:513–518. [DOI] [PubMed] [Google Scholar]
  86. Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., and Grady, P. A. (1985). Evidence for a ‘paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res.326:47–63. [DOI] [PubMed] [Google Scholar]
  87. Revest, P. A., Abbott, N. J., and Gillespie, J. I. (1991). Receptor-mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain Res. 549:159–161. [DOI] [PubMed] [Google Scholar]
  88. Risau, W., and Wolburg, H. (1990). Development of the blood–brain barrier. Trends. Neurosci.13:174–178. [DOI] [PubMed] [Google Scholar]
  89. Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., Morales, J., Tanner, L. I., Tomaselli, K. J., and Bard, F. (1991). A cell culture model of the blood–brain barrier. J. Cell Biol.115:1725–1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Saunders, N. R. (1992). Ontogenetic development of brain barrier mechanisms. In Bradbury, M. W. B. (ed.), Physiology and Pharmacology of the Blood–Brain Barrier, Springer Verlag, Berlin, pp. 327–369. [Google Scholar]
  91. Schroeter, M. L., Mertsch, K., Giese, H., Muller, S., Sporbert, A., Hickel, B., and Blasig, I. E. (1999). Astrocytes enhance radical defence in capillary endothelial cells constituting the blood–brain barrier. FEBS Lett.449:241–244. [DOI] [PubMed] [Google Scholar]
  92. Schulze, C., and Firth, J. A. (1993). Immunohistochemical localization of adherens junction components in blood–brain barrier microvessels of the rat. J. Cell Sci. 104:773–782. [DOI] [PubMed] [Google Scholar]
  93. Segal, M. B., and Zlokovic, B. V. (1990). The Blood–Brain Barrier, Amino Acids and Peptides, Kluwer, Dordrecht, Boston, London. [Google Scholar]
  94. Sipos, I., Dömötör, E., Abbott, N. J., and Adam-Vizi, V. (2000). The pharmacology of nucleotide receptors on primary rat brain endothelial cells grown on a biological extracellular matrix: Effects on intracellular calcium concentration. Br. J. Pharmacol.131:1195–1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Stanness, K. A., Westrum, L. E., Mascagni, P., Fornaciari, E., Nelson, J. A., Stenglein, S. G., and Janigro, D. (1997). Morphological and functional characterization of an in vitro blood–brain barrier model. Brain Res.771:329–342. [DOI] [PubMed] [Google Scholar]
  96. Syková, E., Hansson, E., Rönnbäck, L., and Nicholson, C. (1998). Glial regulation of the neuronal microenvironment. In Laming, P. R., Syková, E., Reichenbach, A., Hatton, G. I., and Bauer, H. (eds.), Glial Cells: Their Role in Behaviour, Cambridge University Press, Cambridge, pp. 130–163. [Google Scholar]
  97. Tontsch, U., and Bauer H.-C. (1991). Glial cells and neurons induce blood–brain barrier related enzymes in cultured cerebral endothelial cells. Brain Res.539:247–253. [DOI] [PubMed] [Google Scholar]
  98. Trepel, M., Arap, W., and Pasqualini, R. (2002). In vivo phage display and vascular heterogeneity: Implications for targeted medicine. Curr. Opin. Chem. Biol. 6:399–404. [DOI] [PubMed] [Google Scholar]
  99. Utsumi, H., Chiba, H., Kamimura, Y., Osanai, M., Igarashi, Y., Tobioka, H., Mori, M., and Sawada, N. (2000). Expression of GFRa-1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB. Am. J. Physiol., Cell Physiol.279:C361–C368. [DOI] [PubMed] [Google Scholar]
  100. Weller, R. O., Kida, S., and Zhang, E.-T. (1992). Pathways of fluid drainage form the brain—morphological aspects and immunological significance in rat and man. Brain Path.2:277–284. [DOI] [PubMed] [Google Scholar]
  101. Westergaard, E., and Brightman, M. W. (1973). Transport of proteins across segments of cerebral arterioles under normal conditions. J. Comp. Neurol.152:17–44. [DOI] [PubMed] [Google Scholar]
  102. Wolburg, H., and Lippoldt, A. (2002). Tight junctions of the blood–brain barrier: Development, composition and regulation. Vasc. Pharmacol.38:332–337. [DOI] [PubMed] [Google Scholar]
  103. Yamagata, K., Tagami, M., Takenaga, F., Yamori, Y., Nara, Y., and Itoh, S. (2003). Polyunsaturated fatty acids induce tight junctions to form in brain capillary endothelial cells. Neuroscience116:649–656. [DOI] [PubMed] [Google Scholar]
  104. Xaio, H., Banks, W. A., Niehoff, M. L., and Morley, J. E. (2001). Effect of LPS on the permeability of the blood–brain barrier to insulin. Brain Res. 896:36–42. [DOI] [PubMed] [Google Scholar]
  105. Zenker, D., Begley, D., Rübsamen-Waigmann, H., and von Briesen, H. (2001). Effects of macrophages on the blood–brain barrier properties of cultured brain capillary endothelial cells. J. Physiol.531P:209P. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Neurobiology are provided here courtesy of Springer

RESOURCES